7FM0 Stock Chart & Stats
€0.09
€0.00(0.00%)
At close: 4:00 PM EDT
€0.09
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€0.05 - €0.35
Previous CloseN/A
Volume0.00
Average Volume (3M)863.00
Market Cap
€3.59M
Enterprise Value€13.67M
Total Cash (Recent Filing)€1.81M
Total Debt (Recent Filing)€11.38M
Price to Earnings (P/E)―
Beta23.91
Next Earnings
Nov 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.25
Shares Outstanding32,793,960
10 Day Avg. Volume0
30 Day Avg. Volume863
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)45.96
Price to Sales (P/S)534.40
P/FCF Ratio-3.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improving Free Cash Flow TrendPositive TTM free-cash-flow growth indicates some improvement in the direction of cash generation, which could become meaningful if sustained. However, the company still reports negative free cash flow, so this is an early trend improvement rather than evidence of self-funding operations.
Healthcare Technology FocusA defined focus on medical and healthcare-related technology gives the company a clear operating identity and potential platform for specialized development. This focus is relevant over multiple quarters, although the available financial evidence does not yet demonstrate meaningful commercial traction.
Lean Organizational StructureA three-person workforce represents a lean organizational structure that may support simpler decision-making and limited administrative complexity. This can help preserve flexibility during development, although the same small scale may constrain execution capacity and does not by itself establish operating strength.
Bears Say
Minimal And Deteriorating RevenueExtremely small and declining revenue indicates limited commercial traction relative to the company’s ongoing cost base. The shift to negative TTM revenue and continued large operating and net losses make earnings quality weak and reduce confidence that the business can scale without significant improvement.
Persistent Cash BurnPersistent negative operating and free cash flow means the business is consuming cash rather than funding operations internally. Worsening TTM operating cash flow increases dependence on external funding, which can limit strategic flexibility and make ongoing operations more vulnerable.
Stressed Balance SheetDebt materially exceeding the equity base, combined with negative TTM equity, signals a highly stressed capital structure. Declining assets further reduce financial flexibility, while elevated refinancing and dilution risk could constrain investment and weaken the company’s ability to absorb setbacks.
Beyond Medical Technologies Inc News
7FM0 FAQ
What was Beyond Medical Technologies Inc’s price range in the past 12 months?
Beyond Medical Technologies Inc lowest stock price was €0.05 and its highest was €0.35 in the past 12 months.
What is Beyond Medical Technologies Inc’s market cap?
Beyond Medical Technologies Inc’s market cap is €3.59M.
When is Beyond Medical Technologies Inc’s upcoming earnings report date?
Beyond Medical Technologies Inc’s upcoming earnings report date is Nov 26, 2026 which is in 49 days.
How were Beyond Medical Technologies Inc’s earnings last quarter?
Beyond Medical Technologies Inc released its earnings results on May 04, 2026. The company reported -€0.061 earnings per share for the quarter.
Is Beyond Medical Technologies Inc overvalued?
According to Wall Street analysts Beyond Medical Technologies Inc’s price is currently Overvalued.
Does Beyond Medical Technologies Inc pay dividends?
Beyond Medical Technologies Inc does not currently pay dividends.
What is Beyond Medical Technologies Inc’s EPS estimate?
Beyond Medical Technologies Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beyond Medical Technologies Inc have?
Beyond Medical Technologies Inc has 32,793,960 shares outstanding.
What happened to Beyond Medical Technologies Inc’s price movement after its last earnings report?
Beyond Medical Technologies Inc reported an EPS of -€0.061 in its last earnings report. Following the earnings report the stock price went up 6.667%.
Which hedge fund is a major shareholder of Beyond Medical Technologies Inc?
Currently, no hedge funds are holding shares in DE:7FM0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Beyond Medical Technologies Inc
Republic Technologies Inc. provides Ethereum-based technology services. The company develops Validity Network, an attestation platform that provides cryptographically secure and tamper-resistant assurances of data integrity by anchoring data commitments directly onto the Ethereum blockchain. It also engages in synthetic mining and validator infrastructure operations. The company was formerly known as Beyond Medical Technologies Inc. and changed its name to Republic Technologies Inc. in July 2025. Republic Technologies Inc. is based in Vancouver, Canada.